Plain-English translation of NCT07195331 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
During gallbladder removal surgery, doctors use a special fluorescent dye called indocyanine green to help them see the bile ducts clearly and avoid damaging them. This trial is comparing two different doses of this dye — a standard dose given several hours before surgery, and a smaller dose given just before surgery — to see which one works better and causes less interference from the liver's natural glow.
Even though gallbladder removal is a common and effective surgery, there is still a risk of accidentally injuring the bile ducts, which can cause serious complications. This study is trying to find the best dose of the fluorescent dye to help surgeons see clearly while reducing unnecessary medication exposure.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the standard dose of fluorescent dye (given 3 or more hours before your surgery) or the smaller dose (given 15–30 minutes before surgery). Both groups will undergo the same laparoscopic gallbladder removal procedure. The surgeon will evaluate how well they can see the bile ducts and how much the liver glows during surgery. You will be monitored for any complications during your hospital stay and for 30 days after surgery.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
Spain